[96a5a0]: / output / allTrials / identified / NCT04248582_identified.json

Download this file

269 lines (269 with data), 11.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
{
"info": {
"nct_id": "NCT04248582",
"official_title": "Phase 1 Dose-Frequency Escalation Study of Neoadjuvant Cryotherapy in Locally Advanced Esophageal Cancer",
"inclusion_criteria": "Adult patients with locally advanced esophageal cancer will be eligible to participate in the study. Eligible patients must have a histologically proven diagnosis of esophageal adenocarcinoma, esophageal squamous cell carcinoma, adenosquamous carcinoma, or gastro-esophageal junctional adenocarcinoma. Locally advanced esophageal cancer will be defined as absence of distant metastases on positron emission tomography-computed tomography (PET-CT) and a TNM stage of IIA to IIIC, as defined by endoscopic ultrasound and PET-CT\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Pediatric patients (age less than 18 years)\n2. Superficial esophageal cancer\n3. Inability to pass the orogastric decompression tube into the stomach\n4. Coagulopathy (INR > 2 or platelet count < 50,000/cubic millimeter).\n5. Inability to provide informed consent\n6. Eastern Cooperative Oncology Group (ECOG) performance status ≥3\n7. Pregnancy",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "Adult patients with locally advanced esophageal cancer will be eligible to participate in the study. Eligible patients must have a histologically proven diagnosis of esophageal adenocarcinoma, esophageal squamous cell carcinoma, adenosquamous carcinoma, or gastro-esophageal junctional adenocarcinoma. Locally advanced esophageal cancer will be defined as absence of distant metastases on positron emission tomography-computed tomography (PET-CT) and a TNM stage of IIA to IIIC, as defined by endoscopic ultrasound and PET-CT",
"criterions": [
{
"exact_snippets": "Adult patients",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "locally advanced esophageal cancer",
"criterion": "esophageal cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced"
]
}
]
},
{
"exact_snippets": "histologically proven diagnosis of esophageal adenocarcinoma, esophageal squamous cell carcinoma, adenosquamous carcinoma, or gastro-esophageal junctional adenocarcinoma",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": [
"esophageal adenocarcinoma",
"esophageal squamous cell carcinoma",
"adenosquamous carcinoma",
"gastro-esophageal junctional adenocarcinoma"
]
}
]
},
{
"exact_snippets": "absence of distant metastases on positron emission tomography-computed tomography (PET-CT)",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "TNM stage of IIA to IIIC, as defined by endoscopic ultrasound and PET-CT",
"criterion": "TNM stage",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2.1,
"unit": "stage"
},
{
"operator": "<=",
"value": 3.3,
"unit": "stage"
}
]
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Pediatric patients (age less than 18 years)",
"criterions": [
{
"exact_snippets": "Pediatric patients (age less than 18 years)",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 18,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "2. Superficial esophageal cancer",
"criterions": [
{
"exact_snippets": "Superficial esophageal cancer",
"criterion": "esophageal cancer",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "superficial"
}
]
}
]
},
{
"line": "3. Inability to pass the orogastric decompression tube into the stomach",
"criterions": [
{
"exact_snippets": "Inability to pass the orogastric decompression tube into the stomach",
"criterion": "orogastric decompression tube passage",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
}
]
},
{
"line": "4. Coagulopathy (INR > 2 or platelet count < 50,000/cubic millimeter).",
"criterions": [
{
"exact_snippets": "Coagulopathy (INR > 2",
"criterion": "INR",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "platelet count < 50,000/cubic millimeter",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 50000,
"unit": "cubic millimeter"
}
}
]
}
]
},
{
"line": "5. Inability to provide informed consent",
"criterions": [
{
"exact_snippets": "Inability to provide informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "6. Eastern Cooperative Oncology Group (ECOG) performance status ≥3",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status ≥3",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "performance status",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "7. Pregnancy",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}